Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise?

With a medicine on the market and plenty of projects in the pipeline, this company's trajectory could be very positive for investors without being a smooth ride.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

Stocks rise as oil dips, yen wobbles ahead of BOJ

SINGAPORE: Asian stocks rose and the dollar held its ground on Friday as investors contended with global policymakers ramping up efforts to rein in inflation, with a dip in oil prices improving sentiment ahead of an expected rate hike from the Bank of Japan.

More from Friday 18 September →